Newron Pharmaceuticals S.p.A. (NWRN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 511.3M |
| Enterprise Value | 537.26M |
| P/E Ratio | -19.6 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 14.35 |
| Price/Book Ratio | -23.69 |
| Enterprise/Revenue | 15.71 |
| Enterprise/EBITDA | -66.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.69 |
| Operating Margin | -0.25 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | 2.78 |
Income Statement
| Revenue | 19.13M |
| Revenue/Share | 0.96 |
| Gross Profit | 19.13M |
| EBITDA | -4.55M |
| Net Income | -13.24M |
| Diluted EPS | -0.67 |
Balance Sheet
| Total Cash | 28.85M |
| Total Cash/Share | 1.45 |
| Total Debt | 38.13M |
| Total Debt/Equity | -3.43 |
| Current Ratio | 0.76 |
| Book Value Per Share | -0.56 |
Price History
| 52-Week Change | 81.01 |
| 52-Week High | 31.85 |
| 52-Week Low | 6.5 |
| Moving Average 50 Days | 14.04 |
| Moving Average 200 Days | 16.57 |
Statistics
| Average Volume | 74,720 |
| Shares Outstanding | 20.81M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
